JENNIFER SHURETTE: Open Payments
NPI 1740929652 · ALEXANDER CITY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$707 in 30 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $210 · 2025 $707
Food & beverage: $707
| Company | Payments | Amount |
|---|---|---|
| ACADIA Pharmaceuticals Inc | 11 | $223 |
| Radius Health, Inc. | 6 | $198 |
| Xeris Pharmaceuticals, Inc. | 3 | $66 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $49 |
| Averitas Pharma Inc. | 1 | $27 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $24 |
| Neurocrine BioSciences, Inc. | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
| Medtronic, Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
Products named: NUPLAZID, Tymlos, GVOKE HYPOPEN, Kerendia, QUTENZA, INGREZZA, XIFAXAN, INPEN SMART INSULIN DELIVERY SYSTEM.
Industry payments across AL — which companies pay providers there.
